Dr. Johannes  Müller

With over 20 years of clinical and executive leadership experience both in biotechnology and medical device companies, Dr. Müller is recognized as an accomplished physician, researcher (German Heart Institute Berlin), entrepreneur, and innovator. In biotechnology, he pioneered the development of immunoadsorption, a process for purifying the blood of autoantibodies implicated - amongst other diseases - in heart failure, and led the first clinical trial to evaluate the effectiveness of immunoadsorption as a heart failure treatment.

Dr. Müller developed the world’s first implantable pediatric cardiac support system and founded Berlin Heart GmbH which produces and markets such system, known as EXCOR®. EXCOR® still remains the only FDA approved cardiac support system for newborns, young children, and adolescents.

Dr. Müller holds a master’s degree in Engineering and a doctorate in electrical engineering and electronics from the Technical University of Berlin. He is also a physician, Dr. med from the Freie Universität Berlin. He has received several national and international awards and has published numerous scientific papers.

At Berlin Heals he is responsible for studies such as CE and FDA and for the further development of the C-MIC Device.